These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32110227)

  • 1. Recurrent Stroke in a Young Patient with Embolic Stroke of Undetermined Source and Patent Foramen Ovale: Quo Vadis?
    Feil K; Heinrich J; von Falkenhausen AS; Becker R; Küpper C; Müller K; Thunstedt DC; Sinner MF; Kääb S; Kellert L
    Case Rep Neurol; 2020; 12(1):45-49. PubMed ID: 32110227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catch-up-ESUS - follow-up in embolic stroke of undetermined source (ESUS) in a prospective, open-label, observational study: study protocol and initial baseline data.
    Feil K; Heinrich J; Küpper C; Müller K; Laub C; von Falkenhausen AS; Becker R; Wollenweber FA; Kääb S; Sinner MF; Kellert L
    BMJ Open; 2019 Dec; 9(12):e031716. PubMed ID: 31822542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Embolic stroke of undetermined source and patent foramen ovale closure: Practice insights from meta-analysis?
    Chatterjee A; Hillegass WB
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):1161-1162. PubMed ID: 30478879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUS.
    Diener HC; Chutinet A; Easton JD; Granger CB; Kleine E; Marquardt L; Meyerhoff J; Zini A; Sacco RL
    Stroke; 2021 Mar; 52(3):1065-1068. PubMed ID: 33504190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embolic Stroke of Undetermined Source and Patent Foramen Ovale: Risk of Paradoxical Embolism Score Validation and Atrial Fibrillation Prediction.
    Strambo D; Sirimarco G; Nannoni S; Perlepe K; Ntaios G; Vemmos K; Michel P
    Stroke; 2021 May; 52(5):1643-1652. PubMed ID: 33784832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.
    Kasner SE; Swaminathan B; Lavados P; Sharma M; Muir K; Veltkamp R; Ameriso SF; Endres M; Lutsep H; Messé SR; Spence JD; Nedeltechev K; Perera K; Santo G; Olavarria V; Lindgren A; Bangdiwala S; Shoamanesh A; Berkowitz SD; Mundl H; Connolly SJ; Hart RG;
    Lancet Neurol; 2018 Dec; 17(12):1053-1060. PubMed ID: 30274772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From cryptogenic to ESUS: Toward precision medicine?
    Timsit S
    Rev Neurol (Paris); 2022 Nov; 178(9):939-952. PubMed ID: 35597610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embolic stroke of undetermined source: Focusing on atrial cardiopathy and patent foramen ovale.
    Zhang M; Xiao Q; Wang K; Yin R; Liu G; Zhao H; Li P; Zhu X; Pan X
    Int J Cardiol; 2024 May; 402():131810. PubMed ID: 38272131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation vs Antiplatelets Across Subgroups of Embolic Stroke of Undetermined Source: A Meta-Analysis of Randomized Controlled Trials.
    Ghannam M; Al-Qudah AM; Alshaer QN; Kronmal R; Ntaios G; Childs CA; Longstreth WT; Alsawareah A; Keller T; Serna-Higuita LM; Geisler T; Furie K; Saver JL; Kasner SE; Elkind MSV; Tirschwell D; Poli S; Kamel H; Yaghi S
    Neurology; 2024 Nov; 103(9):e209949. PubMed ID: 39365971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Embolic Sources in Embolic Stroke of Undetermined Source Patients with Patent Foramen Ovale.
    Toh KZX; Koh MY; Ho JSY; Ong KHX; Lee YQ; Chen X; Fang JT; Chong EY; Lim ICZY; Teo YH; Teo YN; Chua CYK; Lim Y; Chan BPL; Sharma VK; Yeo LLL; Sia CH; Tan BYQ
    Cerebrovasc Dis; 2023; 52(5):503-510. PubMed ID: 36455524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patent Foramen Ovale and Other Cardiopathies as Causes of Embolic Stroke With Unknown Source.
    Kim JS
    J Stroke; 2024 Sep; 26(3):349-359. PubMed ID: 39396831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of Infratentorial Lesion could Predict Patent Foramen Ovale as an Etiology in Embolic Stroke of Undetermined Source.
    Ishizuka K; Toi S; Hoshino T; Higuchi E; Kitagawa K
    J Atheroscler Thromb; 2022 May; 29(5):785-793. PubMed ID: 33952811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating Rates of Recurrent Ischemic Stroke Among Young Adults With Embolic Stroke of Undetermined Source: The Young ESUS Longitudinal Cohort Study.
    Perera KS; de Sa Boasquevisque D; Rao-Melacini P; Taylor A; Cheng A; Hankey GJ; Lee S; Fabregas JM; Ameriso SF; Field TS; Arauz A; Coutts SB; Arnold M; Mikulik R; Toni D; Mandzia J; Veltkamp RC; Meseguer E; Haeusler KG; Hart RG;
    JAMA Neurol; 2022 May; 79(5):450-458. PubMed ID: 35285869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic ischemic lesions and presence of patent foramen ovale in young adults with embolic stroke of undetermined source: Results of the young ESUS patient registry.
    Meinel TR; Tsiplova K; Taylor A; Meseguer E; Haeusler KG; Hart RG; Arnold M; Perera KS
    Int J Stroke; 2024 Apr; 19(4):470-477. PubMed ID: 37981572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptogenic Stroke: Diagnostic Workup and Management.
    Mac Grory B; Flood SP; Apostolidou E; Yaghi S
    Curr Treat Options Cardiovasc Med; 2019 Dec; 21(11):77. PubMed ID: 31792625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview and Future Direction of Embolic Stroke of Undetermined Source from the Insights of CHALLENGE ESUS/CS Registry.
    Kikuno M; Ueno Y
    J Atheroscler Thromb; 2024 Dec; 31(12):1641-1651. PubMed ID: 39343604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patent Foramen Ovale and Stroke-Current Status.
    Bang OY; Lee MJ; Ryoo S; Kim SJ; Kim JW
    J Stroke; 2015 Sep; 17(3):229-37. PubMed ID: 26437990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carotid Atherosclerosis and Patent Foramen Ovale in Embolic Stroke of Undetermined Source.
    Ntaios G; Sagris D; Strambo D; Perlepe K; Sirimarco G; Georgiopoulos G; Nannoni S; Korompoki E; Manios E; Makaritsis K; Vemmos K; Michel P
    J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105409. PubMed ID: 33137616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related burden and characteristics of embolic stroke of undetermined source in the real world clinical practice.
    Grifoni E; Giglio D; Guazzini G; Cosentino E; Latini E; Dei A; Del Rosso A; Guarnaccia V; Baldini M; Bartolozzi ML; Martinucci P; Sani F; Giordano A; Dainelli F; Maggi F; Giulietti C; Romagnoli M; Cinotti S; Schipani E; Murgida GS; Di Martino S; Cozzi A; Carli Ballola A; Dacomo D; Valori D; Masotti L
    J Thromb Thrombolysis; 2020 Jan; 49(1):75-85. PubMed ID: 31494844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embolic Stroke of Undetermined Source: JACC Review Topic of the Week.
    Ntaios G
    J Am Coll Cardiol; 2020 Jan; 75(3):333-340. PubMed ID: 31976872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.